ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways

Sheng-Li Lin(Institute of Zoology), Qing‐Yuan Sun(Institute of Zoology)
PLoS ONE
February 1, 2010
Cited by 122


Related Papers